Jun 09, 2021 7:05am EDT Virios Therapeutics Highlights Safety Data from Phase 2a Fibromyalgia Trial at the International Association for the Study of Pain (IASP) World Congress
Jun 04, 2021 7:05am EDT Virios Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating IMC-1 in Patients with Fibromyalgia
Jun 02, 2021 7:05am EDT Virios Therapeutics Presents Phase 2a Fibromyalgia Trial Data on Efficacy Analyses of Key Secondary Endpoints at the EULAR European Congress of Rheumatology
May 24, 2021 7:05am EDT Virios Therapeutics Announces Oral Presentation of Clinical Data at Digestive Disease Week® (DDW)
May 13, 2021 7:05am EDT Virios Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 06, 2021 7:05am EDT Virios Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on Thursday, May 13, 2021
Apr 16, 2021 7:05am EDT Virios Therapeutics, Inc. Interview to Air on Bloomberg Television U.S. on the RedChip Money Report
Mar 18, 2021 7:05am EDT Virios Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
